~1 spots leftby Jun 2025

InVEST Program for High Risk for Psychosis

(InVEST Trial)

Recruiting in Palo Alto (17 mi)
MF
Overseen byMichelle Friedman-Yakoobian, PHD
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Beth Israel Deaconess Medical Center
Disqualifiers: Full psychosis diagnosis, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to test the efficacy of InVEST (Individualized Vocational and Educational Support and Training) for CHR-P (clinical high risk for psychosis) to address specific role functioning difficulties associated with the CHR-P phase. Our specific goals are: 1. Part 1: Preliminary open trial of InVEST (n = 8) to collect preliminary feasibility and acceptability data by providing the intervention, administering assessments, and collecting focus group and self-report feedback from open trial participants. The open trial phase will help to refine recruitment approaches and to modify the treatment manual as needed. 2. Part 2: Preliminary randomized controlled trial of InVEST vs. Delayed InVEST (DI) to explore preliminary evidence of efficacy of InVEST vs. DI (n = 30). The investigators hope to gain understanding of the feasibility of InVEST and the study's assessment procedures, and to gain a preliminary understanding of the intervention's efficacy for functioning difficulties experienced by young people at CHR-P.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the InVEST treatment for high risk for psychosis?

Research shows that similar programs, like Supported Employment and Education (SEE) using the Individual Placement and Support (IPS) model, improve educational and vocational outcomes for people with early psychosis, suggesting that InVEST could have similar benefits.12345

Is the InVEST Program for High Risk for Psychosis safe for humans?

The research articles do not provide specific safety data for the InVEST Program or its related interventions, but they do mention that early psychosis intervention programs, which include components like supported employment and education, are widely implemented and recommended in guidelines, suggesting a general acceptance of their safety in practice.14567

How is the InVEST treatment different from other treatments for high risk for psychosis?

The InVEST treatment is unique because it focuses on individualized vocational and educational support, specifically targeting educational and employment recovery for those at high risk for psychosis, unlike most treatments that primarily address symptom management and relapse prevention.12589

Research Team

MF

Michelle Friedman-Yakoobian, PHD

Principal Investigator

Department of Psychiatry at BIDMC - a major teaching hospital of Harvard Medical School

Eligibility Criteria

This trial is for English-speaking individuals aged 12-18 who are at high risk for psychosis, as determined by a specific interview process. They must have some difficulty with daily roles and their parent must agree to allow communication between the trial coaches and treatment providers.

Inclusion Criteria

I am between 12 and 22 years old.
Meets broad CHR-P criteria based on the Structured Interview for Psychosis Risk Syndromes (SIPS)
Shows at least mild role functioning impairment on the Global Functioning-Role scale (GF:R)
See 2 more

Exclusion Criteria

Previously met diagnostic criteria for full psychosis on the Structured Interview for Psychosis Risk Syndromes
Does not meet inclusion criteria listed above.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Development Phase/Open Trial

Preliminary open trial of InVEST to collect feasibility and acceptability data, refine recruitment approaches, and modify the treatment manual.

4 months
Weekly sessions (in-person or virtual)

Pilot Study Phase

Randomized trial comparing InVEST treatment vs. Delayed InVEST to explore preliminary evidence of efficacy.

8 months
Weekly sessions (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 months
1 visit (in-person)

Treatment Details

Interventions

  • InVEST (Behavioral Intervention)
Trial OverviewThe InVEST program is being tested in two parts: an initial phase to assess feasibility and refine methods, followed by a randomized controlled trial comparing immediate InVEST intervention against delayed (DI) intervention to evaluate its effectiveness in improving role functioning.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InVESTExperimental Treatment1 Intervention
4 month treatment condition
Group II: delayed investActive Control1 Intervention
participants in delayed invest wait four months and are reassessed before taking part in the intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Beth Israel Deaconess Medical Center

Lead Sponsor

Trials
872
Recruited
12,930,000+
Dr. Kevin Tabb profile image

Dr. Kevin Tabb

Beth Israel Deaconess Medical Center

Chief Executive Officer since 2021

MD from Hebrew University Hadassah Medical School

Dr. Chi Chang Daniel Siao profile image

Dr. Chi Chang Daniel Siao

Beth Israel Deaconess Medical Center

Chief Medical Officer since 2023

MD from King George’s Medical University

Findings from Research

The Individual Placement and Support (IPS) model for first-episode psychosis patients requires an average of 92 minutes per client per week, with a significant portion of time dedicated to direct client contact and travel.
The time commitment for IPS services decreases over the duration of enrollment and is higher when clients are actively seeking work or school placements, suggesting that funding should accommodate the full range of IPS activities to ensure effective support.
Personnel time required for supported employment and education services for individuals in a recent-onset psychosis treatment program.Humensky, JL., Turner, LR., Dixon, LB., et al.[2022]
Introducing a vocational specialist using the individual placement and support (IPS) model significantly reduced unemployment rates from 75% to 62% in young people with psychosis over a 12-month period.
The positive impact on employment was lost after the vocational specialist was withdrawn, highlighting the importance of ongoing support for improving occupational functioning in this population.
Improving vocational outcomes of service users in an Early Intervention in Psychosis service.Dudley, R., Nicholson, M., Stott, P., et al.[2014]
A quality improvement collaborative in the Netherlands successfully implemented three interventions (individual placement and support, cognitive remediation, and shared decision making) for 332 patients with early psychosis over 24 months, achieving moderate-to-high fidelity scores for these interventions.
Despite the successful implementation, the uptake and availability of these interventions showed mixed results, suggesting that a multifaceted approach and careful testing phases are essential for effective integration into services for vocational recovery.
Implementing Evidence-Based Interventions to Improve Vocational Recovery in Early Psychosis: A Quality-Improvement Report.van Duin, D., van Wamel, A., de Winter, L., et al.[2021]

References

Personnel time required for supported employment and education services for individuals in a recent-onset psychosis treatment program. [2022]
Improving vocational outcomes of service users in an Early Intervention in Psychosis service. [2014]
Implementing Evidence-Based Interventions to Improve Vocational Recovery in Early Psychosis: A Quality-Improvement Report. [2021]
Does an integrated outreach intervention targeting multiple stages of early psychosis improve the identification of individuals at clinical high risk? [2019]
Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly): study protocol for a multicenter randomized controlled trial. [2023]
Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults. [2021]
Establishing a clinical service to prevent psychosis: What, how and when? Systematic review. [2023]
Individual placement and support focusing on employment and education for young people at clinical high risk of psychosis: A feasibility study. [2023]
[Early Detection and Intervention for Psychosis: Why and How?] [2022]